OR
ABMD

Olympiad Research’s Abiomed Inc ABMD Stock Holding History

Olympiad Research’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$336K Buy
1,368
+531
+63% +$143K 0.18% 132
2022
Q2 		$207K Buy
837
+91
+12% +$24.6K 0.09% 213
2022
Q1 		$247K Buy
+746
New +$230K 0.08% 232
2020
Q2 		– Sell
-1,892
Closed -$275K – 423
2020
Q1 		$275K Buy
1,892
+11
+0.6% +$1.83K 0.28% 124
2019
Q4 		$321K Buy
+1,881
New +$349K 0.25% 78

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Olympiad Research's ABMD Position: Q3 2022 in Review

Olympiad Research increased its Abiomed Inc (ABMD) stake by 63% in Q3 2022, buying an estimated $143K and bringing the position to 1,368 shares worth $336K. The position accounts for 0.18% of the portfolio, ranked #132.

Olympiad Research first reported a position in ABMD in Q4 2019 and has held it in 5 quarters since. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

  • Olympiad Research held 1,368 shares of Abiomed Inc worth $336K as of Q3 2022.
  • Olympiad Research bought 531 Abiomed Inc shares in Q3 2022, an estimated $143K.
  • Abiomed Inc made up 0.18% of Olympiad Research's portfolio in Q3 2022, its #132 holding.
  • Olympiad Research first reported a position in Abiomed Inc in Q4 2019 and has held it in 5 quarters since.
  • 517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on Olympiad Research's 13F filing for Q3 2022, filed 7 Nov 2022.